The role of estrogen receptors in the control of energy and glucose homeostasis

Steroids

Volumn 73, Issue 9-10, 2008, Pages 874-879

  Ropero, Ana B ^a   Alonso Magdalena, Paloma ^b   Quesada, Ivan ^a   Nadal, Angel ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bisphenol A; Diabetes; Endocrine disruptors; Estrogens; Islet of Langerhans; Metabolic syndrome

Indexed keywords

ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INSULIN; MEMBRANE RECEPTOR;

ADIPOCYTE; ARTICLE; BODY DISTRIBUTION; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPOTHALAMUS; INSULIN RELEASE; INSULIN SENSITIVITY; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL;

ANIMALS; BLOOD GLUCOSE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; INSULIN-SECRETING CELLS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; PANCREAS; RECEPTORS, ESTROGEN; TRANSCRIPTION FACTORS;

MUS;

EID: 44549083871     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2007.12.018     Document Type: Article

References (67)

1. Beato M., and Klug J. Steroid hormone receptors: an update. Hum Reprod Update 6 (2000) 225-236
2. Kelly M.J., and Levin E.R. Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12 (2001) 152-156
3. Nadal A., Diaz M., and Valverde M.A. The estrogen trinity: membrane, cytosolic, and nuclear effects. News Physiol Sci 16 (2001) 251-255
4. Pedram A., Razandi M., Wallace D.C., and Levin E.R. Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell 17 (2006) 2125-2137
5. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
6. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632
7. Nadal A., Ropero A.B., Laribi O., Maillet M., Fuentes E., and Soria B. Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor alpha and estrogen receptor beta. Proc Natl Acad Sci USA 97 (2000) 11603-11608
8. Ropero A.B., Soria B., and Nadal A. A nonclassical estrogen membrane receptor triggers rapid differential actions in the endocrine pancreas. Mol Endocrinol 16 (2002) 497-505
9. Valverde M.A., Rojas P., Amigo J., Cosmelli D., Orio P., Bahamonde M.I., et al. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285 (1999) 1929-1931
10. Lange C.A., Gioeli D., Hammes S.R., and Marker P.C. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu Rev Physiol 69 (2007) 171-199
11. Ropero A.B., Alonso-Magdalena P., Ripoll C., Fuentes E., and Nadal A. Rapid endocrine disruption: environmental estrogen actions triggered outside the nucleus. J Steroid Biochem Mol Biol 102 (2006) 163-169
12. Herman M.A., and Kahn B.B. Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest 116 (2006) 1767-1775
13. Rosen E.D., and Spiegelman B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444 (2006) 847-853
14. Barros R.P., Machado U.F., and Gustafsson J.A. Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 12 (2006) 425-431
15. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., and Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97 (2000) 12729-12734
16. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol 176 (2003) 237-246
17. Barros R.P., Machado U.F., Warner M., and Gustafsson J.A. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci USA 103 (2006) 1605-1608
18. Bryzgalova G., Gao H., Ahren B., Zierath J.R., Galuska D., Steiler T.L., et al. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49 (2006) 588-597
19. Cooke P.S., Heine P.A., Taylor J.A., and Lubahn D.B. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol 178 (2001) 147-154
20. Couse J.F., and Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr Rev 20 (1999) 358-417
21. Naaz A., Zakroczymski M., Heine P., Taylor J., Saunders P., Lubahn D., et al. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res 34 (2002) 758-763
22. Penza M., Montani C., Romani A., Vignolini P., Pampaloni B., Tanini A., et al. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 147 (2006) 5740-5751
23. Shin J.H., Hur J.Y., Seo H.S., Jeong Y.A., Lee J.K., Oh M.J., et al. The ratio of estrogen receptor alpha to estrogen receptor beta in adipose tissue is associated with leptin production and obesity. Steroids 72 (2007) 592-599
24. Musatov S., Chen W., Pfaff D.W., Mobbs C.V., Yang X.J., Clegg D.J., et al. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proc Natl Acad Sci USA 104 (2007) 2501-2506
25. Malaisse W.J., Malaisse-Lagae F., Picard C., and Flament-Durand J. Effects of pregnancy and chorionic growth hormone upon insulin secretion. Endocrinology 84 (1969) 41-44
26. Costrini N.V., and Kalkhoff R.K. Relative effects of pregnancy, estradiol, and progesterone on plasma insulin and pancreatic islet insulin secretion. J Clin Invest 50 (1971) 992-999
27. SutterDub M.T. Preliminary report: effects of female sex hormones on insulin secretion by the perfused rat pancreas. J Physiol (Paris) 72 (1976) 795-800
28. Sutter-Dub M.T. Effects of pregnancy and progesterone and/or oestradiol on the insulin secretion and pancreatic insulin content in the perfused rat pancreas. Diabete Metab 5 (1979) 47-56
29. Brussaard H.E., Gevers Leuven J.A., Frolich M., Kluft C., and Krans H.M. Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM. Diabetologia 40 (1997) 843-849
30. Stevenson J.C., Crook D., Godsland I.F., Collins P., and Whitehead M.I. Hormone replacement therapy and the cardiovascular system: nonlipid effects. Drugs 47 Suppl. 2 (1994) 35-41
31. Le May C., Chu K., Hu M., Ortega C.S., Simpson E.R., Korach K.S., et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103 (2006) 9232-9237
32. Godsland I.F. Oestrogens and insulin secretion. Diabetologia 48 (2005) 2213-2220
33. Livingstone C., and Collison M. Sex steroids and insulin resistance. Clin Sci (Lond) 102 (2002) 151-166
34. Louet J.F., LeMay C., and Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6 (2004) 180-185
35. Gonzalez C., Alonso A., Diaz F., and Patterson A.M. Dose- and time-dependent effects of 17beta-oestradiol on insulin sensitivity in insulin-dependent tissues of rat: implications of IRS-1. J Endocrinol 176 (2003) 367-379
36. Ding E.L., Song Y., Manson J.E., Rifai N., Buring J.E., and Liu S. Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia 50 (2007) 2076-2084
37. Rochira V., Balestrieri A., Madeo B., Spaggiari A., and Carani C. Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men. Mol Cell Endocrinol 193 (2002) 19-28
38. Alonso-Magdalena P., Morimoto S., Ripoll C., Fuentes E., and Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114 (2006) 106-112
39. Alonso-Magdalena P, Ropero AB, Cederroth CR, Baquie M, Gauthier BR, Nef S, et al. Pancreatic insulin content regulation by the estrogen receptor ERalpha; Submitted for publication.
40. 2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 113 (2005) 969-977
41. Nadal A., Ropero A.B., Fuentes E., Soria B., and Ripoll C. Estrogen and xenoestrogen actions on endocrine pancreas: from ion channel modulation to activation of nuclear function. Steroids 69 (2004) 531-536
42. Qiu J., Xue C., Bosch M.A., Murphy J.G., Fan W., Ronnekleiv O.K., et al. Serotonin 5-hydroxytryptamine2C receptor signaling in hypothalamic proopiomelanocortin neurons: role in energy homeostasis in females. Mol Pharmacol 72 (2007) 885-896
43. Rorsman P., Eliasson L., Renstrom E., Gromada J., Barg S., and Gopel S. The cell physiology of biphasic insulin secretion. News Physiol Sci 15 (2000) 72-77
44. Ashcroft F.M., Harrison D.E., and Ashcroft S.J. Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature 312 (1984) 446-448
45. Ripoll C., Martin F., Manuel R.J., Pintor J., Miras-Portugal M.T., and Soria B. Diadenosine polyphosphates: a novel class of glucose-induced intracellular messengers in the pancreatic beta-cell. Diabetes 45 (1996) 1431-1434
46. i in single mouse pancreatic beta-cells. J Physiol 455 (1992) 173-186
47. Nadal A., Quesada I., and Soria B. Homologous and heterologous asynchronicity between identified alpha-, beta- and delta-cells within intact islets of Langerhans in the mouse. J Physiol 517 Pt 1 (1999) 85-93
48. i oscillations due to bursting electrical activity in single pancreatic islets. Pflugers Arch 418 (1991) 417-422
49. 2+ concentration resembling bursting electrical activity in single mouse islets of Langerhans. FEBS Lett 259 (1989) 19-23
50. 2+ as evidences in single pancreatic islets. J Biol Chem 268 (1993) 22265-22268
51. Barbosa R.M., Silva A.M., Tome A.R., Stamford J.A., Santos R.M., and Rosario L.M. Control of pulsatile 5-HT/insulin secretion from single mouse pancreatic islets by intracellular calcium dynamics. J Physiol 510 Pt 1 (1998) 135-143
52. 2+ concentration oscillatory patterns in identified alpha- and beta-cells within intact human islets of Langerhans. Diabetes 55 (2006) 2463-2469
53. Nadal A., Rovira J.M., Laribi O., Leon-quinto T., Andreu E., Ripoll C., et al. Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor. FASEB J 12 (1998) 1341-1348
54. Ropero A.B., Fuentes E., Rovira J.M., Ripoll C., Soria B., and Nadal A. Non-genomic actions of 17beta-oestradiol in mouse pancreatic beta-cells are mediated by a cGMP-dependent protein kinase. J Physiol (Lond) 521 (1999) 397-407
55. Quesada I., Fuentes E., Viso-Leon M.C., Soria B., Ripoll C., and Nadal A. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17beta-estradiol rapidly activate transcription factor CREB. FASEB J 16 (2002) 1671-1673
56. Srivastava D.P., Yu E.J., Kennedy K., Chatwin H., Reale V., Hamon M., et al. Rapid, nongenomic responses to ecdysteroids and catecholamines mediated by a novel Drosophila G-protein-coupled receptor. J Neurosci 25 (2005) 6145-6155
57. 2+ sensitivity of exocytosis in the chick ciliary presynaptic terminal. J Physiol 493 Pt 2 (1996) 385-391
58. Eckhoff D.E., Eckstein C., Smyth C.A., Vilatoba M., Bilbao G., Rahemtulla F.G., et al. Enhanced isolated pancreatic islet recovery and functionality in rats by 17beta-estradiol treatment of brain death donors. Surgery 136 (2004) 336-345
59. Faure A., Sutter-Dub M.T., Sutter B.C., and Assan R. Ovarian-adrenal interactions in regulation of endocrine pancreatic function in the rat. Diabetologia 24 (1983) 122-127
60. Qiu J., Bosch M.A., Tobias S.C., Grandy D.K., Scanlan T.S., Ronnekleiv O.K., et al. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23 (2003) 9529-9540
61. Qiu J., Bosch M.A., Tobias S.C., Krust A., Graham S.M., Murphy S.J., et al. A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. J Neurosci 26 (2006) 5649-5655
62. Gao Q., and Horvath T.L. Neurobiology of feeding and energy expenditure. Annu Rev Neurosci 30 (2007) 367-398
63. Heindel J.J. Endocrine disruptors and the obesity epidemic. Toxicol Sci 76 (2003) 247-249
64. Ropero A.B., Alonso-Magdalena P., Garcia-Garcia E., Ripoll C., Fuentes E., and Nadal A. Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31 (2008) 194-200
65. Grun F., and Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 8 (2007) 161-171
66. Newbold R.R., Padilla-Banks E., Snyder R.J., Phillips T.M., and Jefferson W.N. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 23 (2007) 290-296
67. Rubin B.S., Murray M.K., Damassa D.A., King J.C., and Soto A.M. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 109 (2001) 675-680